Published in N Engl J Med on November 24, 1983
American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritis. Clin J Am Soc Nephrol (2013) 0.80
Complementary medicine. J Gen Intern Med (2013) 0.75
Hospital-acquired renal insufficiency: a prospective study. Am J Med (1983) 5.15
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med (1999) 3.74
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Long-term results of steroid therapy in adults with idiopathic nephrotic syndrome. Am J Med (1969) 2.83
The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med (1994) 2.61
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Arch Intern Med (2001) 2.09
Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol (1987) 2.09
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Our national obsession with potassium. Am J Med (1982) 2.02
Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int (1992) 2.01
The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev (1999) 1.88
Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol (1984) 1.85
Platinum nephrotoxicity. Am J Med (1978) 1.73
Allergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome. N Engl J Med (1973) 1.68
Vascular access for hemodialysis. Kidney Int (1999) 1.65
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol (1999) 1.54
Propagation and regulation of systemic autoimmunity by gammadelta T cells. J Immunol (1996) 1.52
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. Kidney Int (1977) 1.49
The roles of B cells in MRL/lpr murine lupus. Ann N Y Acad Sci (1997) 1.49
Murine lupus in the absence of alpha beta T cells. J Immunol (1996) 1.41
Lupus prone (SWR x NZB)F1 mice produce potentially nephritogenic autoantibodies inherited from the normal SWR parent. J Immunol (1985) 1.37
Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol (1992) 1.34
The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol (1999) 1.30
Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest (1993) 1.30
Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol (1987) 1.27
An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol (1971) 1.27
Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J Immunol (1996) 1.21
Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol (2001) 1.20
Drug-induced hyperkalemia. Medicine (Baltimore) (1985) 1.16
Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest (1997) 1.14
Pathogenic autoantibodies in lupus nephritis. Lupus (2005) 1.11
Renal transplantation in two cases of amyloidosis. Lancet (1971) 1.11
A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol (1989) 1.09
Renal regulation of acid-base equilibrium during chronic administration of mineral acid. J Clin Invest (1974) 1.08
Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int (1996) 1.07
Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse. J Immunol (1993) 1.05
Atheromatous emboli with progressive renal failure. Renal arteriography as the probable inciting factor. Ann Intern Med (1968) 1.03
Continuous peritoneal dialysis for chronic renal failure. Medicine (Baltimore) (1982) 1.02
Hiccip-induced atrioventricular block. Ann Intern Med (1969) 1.02
Fending off the potassium pushers. N Engl J Med (1985) 1.01
Comparative study of in situ immune deposit formation in active and passive Heymann nephritis. Kidney Int (1983) 0.99
Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation. N Engl J Med (1971) 0.99
Mediation of proteinuria in membranous nephropathy due to a planted glomerular antigen. Kidney Int (1983) 0.98
Lupus serum and normal human serum contain anti-DNA antibodies with the same idiotypic marker. J Immunol (1986) 0.98
Factors influencing glomerular and tubulointerstitial patterns of injury in SLE. Am J Kidney Dis (1982) 0.98
Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol (2001) 0.98
Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice. Clin Exp Immunol (1998) 0.97
Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J Autoimmun (1990) 0.97
A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time-and temperature- dependent manner. Lab Invest (1994) 0.96
Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med (1979) 0.96
alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol (1997) 0.96
Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences. J Clin Invest (1993) 0.95
Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice. Int Immunol (2000) 0.94
Clinical disorders of urine concentration and dilution. Arch Intern Med (1973) 0.93
Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int (1980) 0.93
Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane. Kidney Int (1984) 0.92
Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis (1991) 0.92
Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen. Kidney Int (1982) 0.91
Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int (2006) 0.90
Anti-DNA antibodies bind to DNase I. J Exp Med (1995) 0.89
Acute renal failure caused by ureteral obstruction by a gravid uterus. JAMA (1981) 0.89
Renal vein thrombosis. Annu Rev Med (1982) 0.88
Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med (1996) 0.87
Chronic ambulatory peritoneal dialysis. N Engl J Med (1982) 0.87
Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions. J Immunol (1990) 0.85
VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. J558 bias is not limited to classic lupus autoantibodies. J Immunol (1991) 0.85
Measurement of urinary electrolytes - indications and limitations. N Engl J Med (1975) 0.85
Involvement of lymphocyte mediators in the rejection of a murine tumor allograft. Cell Immunol (1977) 0.85
Thrombolytic therapy in renal vein thrombosis. Arch Intern Med (1984) 0.85
Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus. Nephron (1995) 0.85
Cytoplasmic particles and aminoacyl transferase I activity. J Cell Biol (1970) 0.84
Autoreactive T cells from MRL-lpr/lpr mice secrete multiple lymphokines and induce the production of IgG anti-DNA antibodies. J Autoimmun (1991) 0.84
Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research. Clin Exp Rheumatol (2007) 0.84
Restriction fragment length polymorphism analysis of the V kappa locus in human lupus. Eur J Immunol (1989) 0.84
The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol (2000) 0.84
In vitro assessment of delayed hypersensitivity in the human. Inhibition of cell migration from agarose microdroplets. J Immunol Methods (1978) 0.84
Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity. Clin Exp Immunol (2003) 0.83
High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int (2000) 0.83
Macrophage migration from an agarose droplet: a micromethod for assay of delayed hypersensitivity in the mouse. Cell Immunol (1974) 0.83
Charge selective properties of the glomerular capillary wall influence antibody binding in rat membranous nephropathy. Clin Immunol Immunopathol (1986) 0.82
Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol (1996) 0.82
Structural properties of a subset of nephritogenic anti-DNA antibodies. Immunol Res (1994) 0.82
Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int (1998) 0.81
Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies. Immunol Res (1994) 0.81
Primary things first. Acad Med (1997) 0.81
Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up. Arch Intern Med (1977) 0.81
Differing time courses of spleen leukocyte MIF synthesis and cytotoxicity during rejection of a murine lymphoma allograft. Cell Immunol (1976) 0.81
C-terminal peptides from human gamma-chains of differing subclass and allotype. Immunochemistry (1970) 0.81
Structural features of nephritogenic lupus autoantibodies. Methods (1997) 0.80
The metabolic production and disposal of acid and alkali. Med Clin North Am (1970) 0.80
Induction of anti-DNA antibodies in non autoimmune mice by immunization with a DNA-DNAase I complex. Clin Exp Rheumatol (1995) 0.80
Nephrostomy in renal transplantation. Am J Surg (1971) 0.80
Selection of specific phage from display libraries: monoclonal antibody against VCS M13 helper phage coat protein III (gIIIp). Hybridoma (1999) 0.79
Trial of rabbit antihuman ALG in cadaver kidney transplantation. Transplant Proc (1971) 0.79
T cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritis. J Exp Med (1994) 0.79